Premium
NOS1‐derived nitric oxide facilitates macrophage uptake of low‐density lipoprotein
Author(s) -
Roy Anjali,
Banerjee Sreeparna,
Saqib Uzma,
Baig Mirza S.
Publication year - 2019
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.28439
Subject(s) - foam cell , nos1 , macrophage , scavenger receptor , nitric oxide , chemistry , microbiology and biotechnology , low density lipoprotein , lipoprotein , biophysics , biochemistry , biology , cholesterol , nitric oxide synthase , in vitro , organic chemistry
Foam cell formation is a hallmark event during atherosclerosis. The current paradigm is that lipid uptake by a scavenger receptor in macrophages initiates necrosis core formation that characterizes atherosclerosis. We report that NOS1‐derived nitric oxide (NO) facilitates low‐density lipoprotein (LDL) uptake by macrophages independent of the inflammatory response. LDL uptake could be dramatically suppressed by NOS1 specific inhibitor 1‐(2‐trifluoromethylphenyl) imidazole (TRIM). Importantly, the notion that NOS1 can mediate uptake of lipoproteins suggests that the foam cell formation is regulated by NOS1‐derived NO‐mediated mechanism. This is a novel study involving NOS1 as a critical player of foam cell formation and reveals much about the key molecular proteins involved in atherosclerosis. Targeting NOS1 would be a useful strategy in reducing LDL uptake by macrophages and hence dampening the atherosclerosis progression.